KT&G

KT&G R&D per Employee

The R&D Spending per Employee of KT&G (033780.KS) as of Oct 20, 2026 is 16.40 M KRW. In the previous year, R&D Spending per Employee was 14.62 M KRW — a change of 12.21% (higher).

R&D per Employee

16.40 MKRW

YoY

12.21%

Last updated:

R&D Spending per Employee of KT&G is 2025 16.40 M KRW. R&D Spending per Employee of KT&G was 2024 14.62 M KRW. It decreases by 12.21% higher compared to the previous year.

The KT&G R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
10.52 M KRW
Jan 1, 2019
12.11 M KRW
Jan 1, 2020
12.85 M KRW
Jan 1, 2021
15.49 M KRW
Jan 1, 2022
12.32 M KRW
Jan 1, 2023
12.35 M KRW
Jan 1, 2024
14.62 M KRW
Jan 1, 2025
16.40 M KRW
The KT&G R&D per Employee history
YEARR&D per EmployeeYoY
16.40 MKRW+12.21%
14.62 MKRW+18.36%
12.35 MKRW+0.25%
12.32 MKRW-20.48%
15.49 MKRW+20.52%
12.85 MKRW+6.14%
12.11 MKRW+15.12%
10.52 MKRW-0.93%
10.62 MKRW+16.24%
9.13 MKRW+3.99%
8.78 MKRW-1.75%
8.94 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KT&G Stock analysis

What does KT&G do? KT&G Corp is a South Korean company that was originally established as a state monopoly for tobacco products. The abbreviation KT&G stands for Korean Tobacco & Ginseng Society. Today, the company operates in various business sectors and is headquartered in Daejeon, South Korea. History: KT&G was founded in 1899 when Korea was still under Japanese occupation. Originally, the company was named "Chosun Tobacco Monopoly Corporation" and produced tobacco for the Korean market. After World War II and Korea's independence, the company was renamed "Korean Tobacco & Ginseng Society" and the monopoly on tobacco production and sales continued. It was not until the 1980s, under more liberal governments, that the tobacco monopoly was broken, increasing the company's competitiveness. In 1994, KT&G was converted into a joint-stock company and in 2002, the company went public. Today, KT&G is one of the leading companies in Korean tobacco and ginseng products with subsidiaries and business sectors both domestically and internationally. Business Model: KT&G is engaged in various business sectors. Its core business fields include tobacco products, ginseng products, biotechnology, pharmaceuticals, and dietary supplements. Additionally, the company has various joint ventures and subsidiaries in Asia, Europe, and North America. Tobacco Products: KT&G is the largest tobacco manufacturer in Korea and exports its products to over 50 countries worldwide. The company is known for its brands "Esse," "The One," "Raison," and "Timeless." KT&G produces its products in various forms, including cigarettes, cigars, loose tobacco, and pipe tobacco. The company places great importance on research and development to produce innovative products with low levels of harmful substances. Ginseng Products: KT&G has also specialized in the production and sale of ginseng products. Ginseng is an Asian plant known for its health-promoting properties and versatile use in traditional Korean medicine. KT&G produces ginseng extracts, capsules, and beverages, distributing them both domestically and internationally. The brand "Cheong-Kwan-Jang" is synonymous with high-quality ginseng products that are highly valued in Korea and worldwide. Biotechnology and Pharmaceuticals: KT&G also operates in the field of biotechnology and pharmaceuticals. The company has research and development programs for cancer treatments, vascular diseases, and cosmetic products. Dietary Supplements: Dietary supplements are another major business field for KT&G. The company produces vitamin and mineral supplements, herbal extracts, and other dietary supplements aimed at promoting health and well-being. Subsidiaries and Joint Ventures: KT&G has various subsidiaries and joint ventures in Asia, Europe, and North America. These include the "KT&G Sangsangmadang" brand lifestyle culture centers, the "KT&G Towers" skyscraper in Seoul, and the "KT&G Life & Science Center" in Daejeon. Conclusion: KT&G has evolved from a state tobacco monopoly into a diversified multinational corporation operating in various business sectors, including tobacco products, ginseng products, biotechnology, pharmaceuticals, and dietary supplements. KT&G is known in Korea and around the world for its innovative products and commitment to improving the health and well-being of its customers. KT&G is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KT&G stock

R&D Spending per Employee of KT&G is 16.40 M KRW in 2025.

R&D Spending per Employee of KT&G changed from 14.62 M KRW to 16.40 M KRW, representing a 12.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee KT&G since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's KT&G historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — KT&G

All Key Metrics — KT&G